Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus in Minimal-Change Nephrotic Syndrome
NCT01763580Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2012
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus + Wuzhi capsule in nephrosis, sponsored by Astellas Pharma. Started Jul 2012; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
nephrosis
Beyond the preview
Go deeper on NCT01763580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763580.